CDSCO to get a new name; govt invites suggestions from stakeholders

The government has requested all stakeholders to send in their suggestions and comments on the new name and design of the new logo

CDSCO logo
CDSCO logo
Sohini Das Mumbai
Last Updated : Sep 07 2018 | 12:35 AM IST
The Central Drugs Standard Control Organisation (CDSCO), India's national drug regulatory agency, is set to be renamed soon to the one more in line with its current role.

The government has requested all stakeholders to send in their suggestions and comments on the new name and design of the new logo.

On Thursday, the government issued a public notice which said that the present nomenclature does not reflect the role and responsibilities of the CDSCO. 

"Over the years, the CDSCO's role has expanded to several areas including regulation of new drugs including vaccines and clinical trials, imports pertaining to drugs, medical devices and cosmetics, central licensing authority for blood banks etc, setting of standards under the Drugs and Cosmetics Act, 1940, emerging areas such as stem cells, e-pharmacy etc," the notice said. 

Dr R A Mashelkar (who headed the expert committee on drug regulatory system) in his report recommended the creation of a National Drug Authority (NDA) or Central Drug Authority (CDA). The Drug Technical Advisory Board (DTAB) recommended renaming the CDSCO as Indian Drug Administration (IDA).

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story